SG11202100312RA - System and method for determining lung health - Google Patents

System and method for determining lung health

Info

Publication number
SG11202100312RA
SG11202100312RA SG11202100312RA SG11202100312RA SG11202100312RA SG 11202100312R A SG11202100312R A SG 11202100312RA SG 11202100312R A SG11202100312R A SG 11202100312RA SG 11202100312R A SG11202100312R A SG 11202100312RA SG 11202100312R A SG11202100312R A SG 11202100312RA
Authority
SG
Singapore
Prior art keywords
lung health
determining lung
determining
health
lung
Prior art date
Application number
SG11202100312RA
Inventor
Vivienne Rebel
Original Assignee
Bioaffinity Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioaffinity Technologies Inc filed Critical Bioaffinity Technologies Inc
Publication of SG11202100312RA publication Critical patent/SG11202100312RA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57423Specifically defined cancers of lung
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases
    • G01N2800/122Chronic or obstructive airway disorders, e.g. asthma COPD
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
SG11202100312RA 2018-04-13 2019-04-15 System and method for determining lung health SG11202100312RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862657584P 2018-04-13 2018-04-13
PCT/US2019/027550 WO2019200403A2 (en) 2018-04-13 2019-04-15 System and method for determining lung health

Publications (1)

Publication Number Publication Date
SG11202100312RA true SG11202100312RA (en) 2021-02-25

Family

ID=68164530

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202100312RA SG11202100312RA (en) 2018-04-13 2019-04-15 System and method for determining lung health

Country Status (9)

Country Link
US (1) US20210102957A1 (en)
EP (1) EP3775164A4 (en)
JP (1) JP2021521466A (en)
CN (1) CN112424341A (en)
AU (1) AU2019253111A1 (en)
CA (1) CA3136245A1 (en)
MX (1) MX2020010825A (en)
SG (1) SG11202100312RA (en)
WO (1) WO2019200403A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111693445A (en) * 2020-06-05 2020-09-22 北京卓诚惠生生物科技股份有限公司 Method for detecting immune cells in sputum
WO2023114538A2 (en) * 2021-12-17 2023-06-22 Bioaffinity Technologies, Inc. Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning
WO2024006142A1 (en) * 2022-07-01 2024-01-04 Bioaffinity Technologies, Inc. Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE541214T1 (en) * 2000-11-17 2012-01-15 Biomoda Inc COMPOSITIONS AND METHODS FOR DETECTING PRECANCEROUS CONDITIONS IN CELL AND TISSUE SAMPLES USING 5,10,15,20-TETRAKIS(CARBOPHENYL)PORPHINE
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
US20110189670A1 (en) * 2008-07-07 2011-08-04 Ruth L Katz Circulating Tumor and Tumor Stem Cell Detection Using Genomic Specific Probes

Also Published As

Publication number Publication date
EP3775164A4 (en) 2022-11-02
CN112424341A (en) 2021-02-26
AU2019253111A1 (en) 2020-11-26
WO2019200403A3 (en) 2019-11-28
US20210102957A1 (en) 2021-04-08
MX2020010825A (en) 2021-01-15
JP2021521466A (en) 2021-08-26
CA3136245A1 (en) 2019-10-17
WO2019200403A2 (en) 2019-10-17
EP3775164A2 (en) 2021-02-17

Similar Documents

Publication Publication Date Title
EP3684248C0 (en) Method and apparatus for determining health status
SG11201803460TA (en) Route determining method and corresponding apparatus and system
GB2595423B (en) Biosensor conditioning method and system
GB201821278D0 (en) Drone-based cleaning method and system
GB2584251B (en) Method and system for customized content
GB2573692B (en) Analysis system and analysis method
SG11202009102QA (en) System and method for non-invasive ventilation
EP3549650C0 (en) System and method for assisted construction
SG11202100312RA (en) System and method for determining lung health
GB2572677B (en) System and method
SG11202000002TA (en) System and method for determining event
GB201818741D0 (en) Diagnostic system and method
ZA202100422B (en) System and method for moisture measurement
SG11202013146XA (en) Structural health monitoring method and system
PL3791156T3 (en) Method and system for cleaning an inline sensor
GB201809582D0 (en) System and method
GB201803940D0 (en) Methods and systems for analysis
EP4025875C0 (en) Method and system for determining position displacments
SG11202109094RA (en) Apparatus evaluation system and apparatus evaluation method
GB201816668D0 (en) System and method
GB201814966D0 (en) System and method for determining accelerometer orientation
GB201812593D0 (en) Illimination system and method
GB2597202B (en) Analysis system and analysis method
EP3863857C0 (en) Cleaning system and method
GB201615277D0 (en) Method and apparatus for quantifying lung function